High prevalence of activated protein C resistance in patients with systemic sclerosis

International Journal of Clinical and Laboratory Research

Volumn 25, Issue 4, 1995, Pages 226-227

  De Lucia, D ^a   De Blasio, G ^a   Belli, A ^a   Conte, M ^a   Renis, V ^a   Di Mauro, C ^a   Tortora, V ^a   Valentini, G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Activated protein C resistance; Systemic sclerosis

Indexed keywords

PROTEIN C;

BLOOD CLOTTING TEST; FEMALE; HUMAN; IMMUNOLOGY; LETTER; MALE; PREVALENCE; SYSTEMIC SCLEROSIS;

BLOOD COAGULATION TESTS; FEMALE; HUMANS; MALE; PREVALENCE; PROTEIN C; SCLERODERMA, SYSTEMIC;

EID: 0029440320     PISSN: 09405437     EISSN: 14344467     Source Type: Journal    
DOI: 10.1007/BF02592703     Document Type: Letter

References (8)

1. Systemic sclerosis (scleroderma) and related disorders
2. Whole platelet aggregation and coagulation factors in patients with systemic sclerosis
3. Venous blood fibrinolysis and fibronolytic potential in primary Raynaud's phenomenon and systemic sclerosis associated Raynaud's phenomenon
4. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor response to activated protein
5. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene
6. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
7. Mutation in blood coagulation factor V associated with resistance to activated protein C
8. Influence of lupus anticoagulant on a commercially available kit for APC-resistance